America

2024

Base

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noreferrer noopener" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div> 
<p class="has-drop-cap">Colgate-Palmolive Co. (NYSE: CL) has reported a robust performance for the <a href="https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-announces-2nd-quarter-2024-results" target="_blank" aria-label="second quarter of 2024 (opens in a new tab)" rel="noreferrer noopener nofollow" class="deco-link">second quarter of 2024</a>, showcasing solid growth across various metrics. Net sales for the quarter reached $5.058 billion, reflecting a 4.9% increase from the previous year’s $4.822 billion. <br><br>Organic sales grew by an impressive 9.0%, driven by a balanced mix of volume growth and higher pricing. The company also saw a significant rise in its gross profit margins, with GAAP gross profit margin expanding by 280 basis points to 60.6%, and Base Business gross profit margin increasing by 300 basis points to 60.8%.</p> 
<p>In terms of earnings, Colgate-Palmolive reported a GAAP <a href="https://tokenist.com/investing/how-to-value-a-stock/" rel="dofollow" class="deco-link">EPS</a> of $0.89, marking a 48% increase from the $0.60 recorded in the same quarter last year. The adjusted EPS also saw an 18% rise, reaching $0.91 compared to $0.77 in the previous year. <br><br>The company’s net cash provided by operations for the first six months of 2024 was $1.671 billion. Colgate-Palmolive maintained its leadership in the oral care market, holding a global market share of 41.5% in toothpaste and 32.2% in manual toothbrushes.</p> 
<h3 id="colgate-palmolive-exceeds-analyst-expectations-in-q2">Colgate-Palmolive Exceeds Analyst Expectations in Q2</h3> 
<p>When comparing the current performance against market expectations, Colgate-Palmolive exceeded analysts’ predictions. <br><br>The market had anticipated an EPS of $0.86 and revenue of $5.01 billion for the quarter. However, the company reported an EPS of $0.89 and revenue of $5.058 billion, surpassing both metrics. This outperformance can be attributed to strong organic sales growth and effective pricing strategies.</p> 
<p>The company’s organic sales growth of 9.0% significantly outstripped the expectations, which were in the range of 5% to 7%. Colgate-Palmolive’s ability to deliver higher-than-expected earnings and sales highlights its operational efficiency and market strength. The increase in advertising investment by 18% during the quarter also indicates the company’s commitment to sustaining long-term growth.</p> 
<div class="cta-referral"> 
 <img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async"> 
 <div class="cta-referral__text"> 
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noreferrer noopener nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p> 
 </div> 
</div> 
<h3 id="guidance">Guidance</h3> 
<p>Looking ahead, Colgate-Palmolive has updated its financial guidance for the full year 2024. The company now expects net sales growth of 2% to 5%, accounting for a mid-single-digit negative impact from foreign exchange. <br><br>The guidance for organic sales growth has been raised to 6% to 8%, up from the previous 5% to 7%. This optimistic outlook is based on the company’s strong performance in the first half of the year and its strategic initiatives aimed at driving growth.</p> 
<p>On a GAAP basis, Colgate-Palmolive continues to anticipate gross profit margin expansion, increased advertising investment, and double-digit earnings per share growth. For its Base Business, the company has increased its earnings per share growth guidance to 8% to 11%, up from the prior mid to high-single-digit range. This revised guidance reflects the company’s confidence in its ability to sustain its growth momentum.</p> 
<p>The divisional performance for the second quarter also paints a positive picture. North America saw a 2.5% increase in net and organic sales, while Latin America reported a remarkable 7.6% rise in net sales and an 18.8% surge in organic sales. Europe, Asia Pacific, and Africa/Eurasia also posted solid growth, contributing to the overall positive performance. <br><br>Hill’s Pet Nutrition division, which represents 22% of the total company sales, reported a 5.5% increase in net sales and a 6.1% rise in organic sales.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe> 
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p> 
<h3 id="br"><br></h3> 
<p>The post <a rel="nofollow" href="https://tokenist.com/colgate-palmolive-exceeds-market-expectations-with-0-91-eps/">Colgate-Palmolive Exceeds Q2 Market Expectations with $0.91 EPS</a> appeared first on <a rel="nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Colgate-Palmolive Exceeds Q2 Market Expectations with $0.91 EPS

Table of Contents

Tokenist

Andre artikler udgivet 26. jul. 2024

Polymath (POLY) Price Prediction 2025, 2026, 2027, 2028, 2029 and 2030

How decentralization could have prevented the global Microsoft meltdown

While Cardano Eyes an 81% Gain & Toncoin Faces Volatility, BlockDAG Predicts a Stellar 30,000x RO...

High-Profile Crypto Donors Show Support for Donald Trump, Why Though?

Dogecoin(DOGE) Price Preparing for a Fresh Move: May Reach $0.5 in the Next Few Months

Mt. Gox Bitcoin Dump vs Ethereum ETF Launch Week🔥

Join our free newsletter for daily crypto updates!